European Hashish Week 2025 has formally begun, seeing hundreds of Europe’s hashish thought leaders, innovators and choice makers descend on Berlin’s huge Messe Berlin for the primary day of Mary Jane Berlin. 

This 12 months, for the primary time, Enterprise of Hashish has partnered with Mary Jane to launch a devoted Enterprise-to-Enterprise Day, for a novel alternative to foster collaboration, drive innovation and discover the rising alternatives throughout the European hashish market. 

With the German hashish market projected to succeed in €1.7 billion by 2028, in accordance with the not too long ago launched Prohibition Companions German Hashish Report, the occasion will present a crucial platform for worldwide hashish companies to have interaction with native stakeholders and acquire insights into the brand new regulatory framework and industrial alternatives rising in Germany.

We’ll be reporting all through the day to carry you a roundup of the important thing insights from the panels as they occur.

Increasing Past Borders – Methods for Worldwide Development

How hashish corporations can navigate advanced worldwide laws, particularly in Europe, and construct sustainable market entry methods.

UK Market Outlook

• Robert Jappie (Fieldfisher) famous that UK market development has been sluggish — round 70,000–80,000 sufferers over seven years — however key limitations are actually easing. He expects important development forward.

• UK is usually ignored in favour of Germany, however Jappie believes it’s not far behind and presents actual alternative.

• Branding is enjoying a rising position within the UK, significantly for Canadian merchandise — customers are keen to pay for trusted names.

• Karan Wadhera (Casa Verde) remarked how few individuals within the UK realise that medical hashish is already authorized. That is largely resulting from promoting restrictions, although corporations are more and more discovering workarounds.

International Technique & Model Constructing

• Jürgen Bickel (STORZ & BICKEL) stated his firm has shipped to over 120 international locations. In his 25 years within the sector, progress has at all times been sluggish, however it persistently strikes ahead.

• Each market is “fascinating,” with Germany, Australia, and now the UK providing sturdy alternatives.

• Resulting from strict advertising guidelines, social media and digital channels (like podcasts and Instagram) are important for constructing model identification in hashish.

Clinics, Affected person Retention & M&A

• Jappie recognized affected person acquisition as the largest alternative within the UK. The remainder of the availability chain is already crowded.

• Clinics that focus on the cannabis-naive inhabitants are seeing the perfect development and are more and more enticing for funding.

• Poor affected person retention was a significant motive for early UK stagnation.

• Bickel agreed that telemedicine has improved entry however not retention. He added that compliance, whereas expensive, is a crucial differentiator in M&A offers.

• New medical system laws and licensing necessities make operations extra advanced — however those that handle them nicely stand out.

 Regulation & Cultural Normalisation

• Yuval Soiref (Inexperienced Success 1.0) stated success usually comes right down to being first and being sensible — citing STORZ & BICKEL for example.

• Jappie warned that lack of regulatory readability invitations risk-taking. In Germany, for instance, the telemedicine increase might now be attracting stricter scrutiny from regulators.

• Bickel burdened the necessity to normalise hashish politically — legalisation in Germany will not be the endpoint. With out ongoing advocacy, the trade might lose floor.

• Soiref agreed: continued regulatory progress is important, each for enterprise and for affected person entry.

Blurred Strains – The place Medical and Leisure Hashish Overlap

As Europe’s hashish markets evolve, the division between medical and leisure use is turning into more and more ambiguous — creating each alternatives and challenges for regulators, medical doctors, and companies alike.

Medical vs. Leisure: A Shifting Divide

• Lisa Haag (MJ Universe GmbH) opened by noting that the problem lies in the truth that it’s the similar hashish, however utilized by very completely different individuals — making it more and more tough to separate medical from leisure use in a significant approach.
• Paul Furfaro (Village Farms Worldwide) shared classes from Canada, the place the hashish market flipped dramatically after legalisation: what was as soon as 85–90% medical is now overwhelmingly leisure. Regardless of this, he burdened the significance of defending entry for persistent sickness sufferers, who depend on hashish as a crucial a part of their care.
• Furfaro additionally emphasised that product positioning and messaging are actually extra necessary than ever, as advertising methods usually blur the strains between therapeutic and life-style use — creating potential confusion for customers and regulators alike.

Self-Analysis and the Function of the Physician

• Lisa Haag launched the idea of “secret people who smoke” — people who bypass the medical system fully, self-diagnosing and turning to leisure markets for what are successfully medical wants.
• Paul Furfaro warned that this pattern contributes to misinformation and potential hurt, as individuals usually depend on anecdotal sources or unverified claims as an alternative {of professional} medical recommendation. With out correct medical steerage, dosing, and monitoring, outcomes can range dramatically.

Cultural Gaps and Scientific Dangers

• Huge Narstie (Huge Narstie Medical) provided a candid evaluation of the UK’s medical hashish panorama, arguing {that a} lack of coaching and assist for medical doctors is likely one of the greatest limitations to entry. Many GPs, he stated, are hesitant to prescribe hashish as a result of they’re unfamiliar with it and fearful {of professional} penalties.
• He defined that this vacuum has allowed the leisure market to innovate quickly, with product varieties, codecs, and flavours that medical doctors not often encounter. Nonetheless, he maintained that the medical pathway stays the safer, extra sustainable choice — even when it’s not as user-friendly.
• “Hashish is a medication of style,” he stated, highlighting that not like drugs, hashish requires individualised choice — one thing leisure platforms are at the moment higher geared up to supply.

Platforms, Danger Mitigation & Regulation

• Dr. Jur Can Ansay (Dr. Ansay LTD) spoke in regards to the German context, the place telemedicine has grow to be important to affected person entry as a result of shortage of cannabis-literate physicians.
• He defined that his platform serves not simply as a prescription service but in addition as a risk-mitigation software, flagging points like dependancy danger — a characteristic he stated stays uncommon within the trade.
• Nonetheless, he famous that the convenience of entry has reached a brand new excessive: in some instances, sufferers can now receive hashish “as simply as ordering a pizza,” reflecting each progress and the pressing want for tighter medical oversight.

Workshop Stage: Sizing Up the German Medical Hashish Market – A Knowledge and Numbers Deep Dive

  Pablo Zuanic, Managing Director, Zuanic and Associates, provides an in depth, data-rich evaluation of Germany’s medical hashish sector, exploring affected person entry, import volumes, pricing, and reimbursement,  together with the broader market forces shaping its future.

Market Insights & Qualitative Developments

• Zuanic emphasised that main information gaps persist throughout the European hashish market, significantly in monitoring imports, pharmacy-level gross sales, and product rejections.

• The German market continues to point out indicators of rising affected person entry, medical legitimacy, and investor potential, with hashish more and more seen as an ordinary a part of therapeutic care.

Import Volumes & Market Sizing

• Since CanG took impact, medical hashish imports have elevated fivefold, a robust indicator of rising demand and improved entry infrastructure.

• Roughly 60% of imports are believed to succeed in pharmacies, with the remaining 40% misplaced or rejected, although questions stay about why a lot doesn’t make it to pharmacy.

• Primarily based on accessible information, the estimated German market worth utilizing a €7/gram common is roughly €625 million. With larger volumes and pricing nearer to €10/gram, that determine might exceed €1 billion.

Affected person Penetration & Market Potential

• Lively medical hashish customers are estimated to signify 0.4% of the German inhabitants, or roughly 338,000 sufferers, nonetheless far under North American benchmarks (~4%), however a robust start line for long-term development.

• If Germany had been to succeed in North American ranges of penetration, the market might be value upwards of €70 billion, although Zuanic burdened that this can be a directional benchmark fairly than a strict forecast.

Money vs. Reimbursed Prescriptions

• In H1 2024, medical hashish reimbursement — excluding Epidyolex, dronabinol, and different pharma cannabinoids — totalled €68 million, a 13% year-on-year improve.

• Reimbursement is now estimated at €150 million yearly, suggesting that round 20% of the market is roofed by insurance coverage, up from 10% beforehand.

• That leaves roughly 80% of the market as  money pay

Product Combine & Therapy Shifts

• Extracts now account for 30% of the reimbursed market, whereas flower nonetheless dominates, making up an estimated 94% of complete gross sales when combining each money and reimbursed segments.

• Zuanic noticed a gradual shift towards medical-focused prescriptions, and an rising sophistication in how hashish is being built-in into remedy plans, particularly with extra advanced merchandise.

Market Dynamics & Export Affect

• Stabilising hashish costs are partly pushed by export-oriented markets like Germany and Australia, that are serving to create international worth anchors.

• The elevated give attention to extracts and the emergence of telemedicine platforms are reshaping how hashish is prescribed and accessed — significantly in Germany.

 Funding & Regulatory Outlook

• Germany presents clear upside potential for traders, particularly as affected person entry improves and the sector turns into extra structured.

• The normalisation of hashish throughout the healthcare system is accelerating, even when regulation nonetheless lags behind precise affected person demand.

• Zuanic concluded that the sector is shifting from uncertainty to extend legitimacy and maturity, however success relies on higher information transparency, regulatory readability, and cross-border studying from extra established markets.